<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Shuman, Jill</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Blanc, Jean-Jacques</style></author><author><style face="normal" font="default" size="100%">Glikson, Michael</style></author><author><style face="normal" font="default" size="100%">Gasparini, Maurizio</style></author><author><style face="normal" font="default" size="100%">Singh, Jagmeet</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Issues in Cardiac Resynchronization Therapy</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-11-09 11:22:16</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">5-6</style></pages><abstract><style  face="normal" font="default" size="100%">A panel of 4 experts explored clinical guidelines regarding pacing, implantable cardioverter-defibrillators, and cardiac resynchronization therapy. Two speakers also debated clinical, financial, and ethical questions related to continued use of cardiac resynchronization therapy in the setting of clinical improvement, such as an improved left ventricular ejection fraction.</style></abstract><number><style face="normal" font="default" size="100%">28 suppl 2</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>